New finance director installed at Regus Business Centres

Until December 1999 Stamp, 38, was finance director of the rapidly expanding specialist pharmaceuticals company, Shire Pharmaceuticals. In his time there the group grew from its flotation value of £106m in 1996 to £1.6bn in December 1999 following the completion of its merger with Roberts Pharmaceutical Corporation of the US.

Prior to joining Shire in 1994, Stamp was an assistant director, corporate finance at Lazard Brothers in London, having previously spent four years at KPMG Peat Marwick, where he trained.

Mark Dixon, Executive Chairman of Regus, said: ‘Stephen’s knowledge of the workings of the capital markets and his background in the City will be of great assistance to Regus as the company enters what will be an important and exciting year in its development.

‘In addition, his experience in the US, where he has been involved in building a substantial presence for Shire and in achieving a listing for Shire on NASDAQ, will also be of enormous value to Regus as our business expands in that market.’

Regus UK

Related reading